Methasan

Methadone Hydrochloride, the active ingredient in Methasan, is an opioid presented as an oral formulation for oral use. Originating from the European Union market, it is used to treat opioid dependence and chronic pain by providing sustained analgesia and suppressing withdrawal symptoms in adult patients.

GNH USA supplies Methasan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent product quality, regulatory adherence, and reliable logistics for global healthcare providers, including both public and private sector institutions, with support for import documentation and temperature‑controlled shipping where required.

Methadone Hydrochloride is an opioid analgesic that acts on the mu‑opioid receptor system.

Opioid dependence treatment: reduces withdrawal symptoms and cravings, facilitating maintenance therapy. Chronic pain management: provides long‑acting analgesia for severe, persistent pain. Opioid detoxification: assists in medically supervised withdrawal by stabilizing opioid levels.

Methadone Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Constipation - Drowsiness - Sweating - Dry mouth - Dizziness

Serious or Rare Side Effects: - Respiratory depression - QT interval prolongation - Severe hypotension - Adrenal insufficiency - Seizures - Cardiac arrhythmias

When prescribing Methadone Hydrochloride, clinicians should observe several safety measures.

Assess patient history: evaluate prior opioid use, respiratory disorders, and cardiac conditions. Monitor respiratory function: observe for signs of depression, especially during dose initiation or adjustments. Avoid use in severe hepatic impairment: liver dysfunction can increase drug levels and toxicity. Use caution with concomitant CNS depressants: combined effects may enhance sedation and respiratory risk. Educate about dependence risk: inform patients of the potential for addiction and the need for controlled use. Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Methadone Hydrochloride interacts with several medications, requiring careful management.

Major Interactions (Avoid): - Other opioids: additive respiratory depression. - Benzodiazepines or other CNS depressants: increased sedation and respiratory risk. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may raise methadone levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may lower methadone concentrations. - QT‑prolonging agents (e.g., antiarrhythmics, certain antipsychotics): increase risk of cardiac arrhythmias.